查詢結果分析
相關文獻
- Advances in the Management of Oxaliplatin-induced Neuropathy: Focus on Glutamine and Using Pharmacogenomics to Predict the Effectiveness of Opioid Drugs
- 新生兒鴉片類藥物戒斷症狀治療
- 5-Fluorouracil的代謝及其高劑量化學治療的神經毒性
- Lofexidine對海洛因戒斷症狀之治療效果: 一開放性試驗
- 二硫化碳之神經毒性
- Altered Intracellular Calcium Level in Association with Neuronal Death Induced by Lithium Chloride
- Deferoxamine之耳神經毒性
- 蜘蛛網膜下腔用藥相關神經毒性的探討
- 礦物類中藥材安全性制定之前導研究--市售朱砂之藥理機制研究(2)
- The Neuroprotective Role of Taurine in Cultured Neurons
頁籤選單縮合
題名 | Advances in the Management of Oxaliplatin-induced Neuropathy: Focus on Glutamine and Using Pharmacogenomics to Predict the Effectiveness of Opioid Drugs=Oxaliplatin神經毒性治療方面的進展:聚焦在麩醯胺酸以及利用基因體多型性來預測鴉片類藥物Oxaliplatin疼痛性神經病變之療效 |
---|---|
作者 | 王緯書; | 書刊名 | 臺灣癌症醫學雜誌 |
卷期 | 1:3 2014.12[民103.12] |
頁次 | 頁175-185 |
分類號 | 418.31 |
關鍵詞 | 神經毒性; 麩醯胺酸; 基因體多型性; 鴉片類藥物; Oxaliplatin; Neuropathy; Glutamine; Genomic polymorphism; Opioid drugs; |
語文 | 英文(English) |
中文摘要 | 神經毒性是 oxaliplatin 治療期間最常見的副作用。根據不同的臨床研究報告, oxaliplatin 所引起的嚴重神經毒性的機率約為 12%至 18%。依症狀之不同,oxaliplatin 神 經毒性可分為兩類。第一類是相當特殊、急性的、暫時性的週邊神經過度敏感現象,通 常在給藥後幾個小時內就會發生。第二類與 cisplatin 引起的神經毒性類似,係發生於肢端末稍的感覺神經病變。這類型的神經毒性會持續數個月,導致神經功能明顯失常,並 有可能會影響後續的治療。目前已有幾種策略用來預防或治療 oxaliplatin 引起的神經毒 性,包括「打打停停」(stop-and-go)策略、鈣及鎂離子的輸注、抗癲癇藥物、glutathione、 xaliproden、非類固醇消炎藥、麩醯胺酸、以及鴉片類藥物等。於本文中,作者聚焦於 oxaliplatin 導致週邊神經病變的機轉、麩醯胺酸用於 oxaliplatin 神經毒性的療效、基因體 多型性所導致鴉片類藥物於 oxaliplatin 疼痛性神經病變療效的差異,以及可否利用神經 傳導速率檢查來客觀評估 oxaliplatin 所引起的神經毒性。 |
英文摘要 | One form of neurotoxicity is the principal and dose-limiting toxicity of oxaliplatin. It has been observed that the incidence of oxaliplatin-induced severe neurotoxicity has varied from 12% to 18% in different clinical trials. Oxaliplatin-induced neuropathy can be divided into two distinct syndromes. The first is a unique syndrome of acute, transient peripheral nerve hyperexcitability occurring shortly after the infusion of oxaliplatin. The second one is a peripheral sensory neuropathy occurring mainly in the distal extremities with symptoms similar to those caused by cisplatin. It may last for several months, and results in a severe disturbance of neurologic function, and has a significant impact on oxaliplatin treatment. Various strategies have been proposed to prevent or treat oxaliplatin-induced neurotoxicity, including the stop-and-go concept, calcium and magnesium infusions, antiepileptic drugs, glutathione, xaliproden, NSAIDs, glutamine, and opioid drugs. In this article, the authors focus on the mechanisms of peripheral neuropathy induced by oxaliplatin, the role of glutamine in the management of oxaliplatin-neuropathy, genomic polymorphisms involved in an altered susceptibility to opioid drugs in managing oxaliplatin-induced neuropathic pain, and the use of nerve conduction velocity studies in objectively assessing oxaliplatin-induced neuropathy. |
本系統之摘要資訊系依該期刊論文摘要之資訊為主。